Related Experiment Video
Updated: Jul 20, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Severe mitral regurgitation from Libman-Sacks endocarditis treated with MitraClip: a case report
Wong Ningyan1, Ignasius Aditya Jappar1, Ewe See Hooi1
1Department of Cardiology, National Heart Centre, 5 Hospital Drive, Singapore 169609, Singapore.
Insights
Transcatheter edge-to-edge repair (TEER) offers a viable treatment for severe mitral regurgitation in systemic lupus erythematosus (SLE) patients, avoiding high-risk surgery.
Area of Science:
- Cardiology
- Rheumatology
- Interventional Cardiology
Background:
- Systemic lupus erythematosus (SLE) can cause valvulopathy, typically treated with surgery.
- SLE patients often have comorbidities, increasing surgical risks and mortality.
- Severe mitral regurgitation (MR) in SLE necessitates treatment but poses challenges.
Observation:
- A 41-year-old woman with SLE and antiphospholipid syndrome presented with severe MR due to Libman-Sacks endocarditis.
- She had multiple comorbidities, including lupus nephritis and respiratory compromise, making her a high surgical risk.
- Her heart failure progressed, with worsening symptoms and reduced left ventricular function.
Findings:
- Transcatheter edge-to-edge repair (TEER) using the MitraClip system was successfully performed.
- The patient improved to New York Heart Association functional Class II with mild MR at 1-month follow-up.
- This indicates a positive outcome for a high-risk patient.
Implications:
- TEER is a potential alternative to surgery for severe MR in SLE patients with suitable anatomy.
- This minimally invasive approach may reduce morbidity and mortality in this vulnerable population.
- Further research should explore TEER's long-term efficacy in SLE valvulopathy.
Background:
Systemic lupus erythematosus (SLE) valvulopathy can manifest as a spectrum of pathologies and treatment of severe valvular dysfunction thus far has been surgical. However, surgery in patients with SLE is frequently associated with high morbidity and mortality due to the presence of significant co-morbidities.
Case Summary:
We report the case of a 41-year-old woman with SLE and anti-phospholipid syndrome with extensive co-morbidities including lupus nephritis, pancytopaenia, cerebrovascular accident, and severe airway obstruction from ipsilateral lung collapse and bronchiectasis. She had severe mitral regurgitation (MR) from Libman-Sacks endocarditis and in recent months developed heart failure with progressive exertional dyspnoea from New York Heart Association (NYHA) functional Class from New York Heart Association (NYHA) functional class II to III. In addition, there was progressive left ventricular dilatation and reduction in left ventricular ejection fraction. In view of the high surgical risk, she underwent transcatheter edge-to-edge repair (TEER) of the mitral valve with the MitraClip system. At 1-month follow-up, she was back to NYHA functional Class II with mild MR.
Discussion:
Our case demonstrates that in select patient with suitable anatomy, TEER is a potential treatment option for severe MR from SLE valvulopathy.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management

